Hypertension and the Cortisol-Cortisone Shuttle
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
11 beta-Hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) plays a crucial role in converting hormonally active cortisol to inactive cortisone, thereby conferring specificity on the mineralocorticoid receptor. Mutations in the gene encoding 11 beta-HSD2 (HSD11B2) account for an inherited form of hypertension, the syndrome of apparent mineralocorticoid excess, in which cortisol induces hypertension and hypokalemia. A similar clinical picture to apparent mineralocorticoid excess occurs after the ingestion of licorice and carbenoxolone, which are competitive inhibitors of 11 beta-HSD2. Reduced 11 beta-HSD2 activity may explain the increased sodium retention in preeclampsia, renal disease, and liver cirrhosis. Substrate saturation of 11 beta-HSD2 occurs in Cushing's syndrome and explains the mineralocorticoid excess state that characterizes ectopic ACTH syndrome. Polymorphic variability in the HSD11B2 gene in part determines salt sensitivity, a forerunner for adult onset hypertension. Furthermore, reduced placental 11 beta-HSD2 expression might underpin the Barker hypothesis, the epidemiological link between reduced birth weight and adult hypertension. At a prereceptor level, 11 beta-HSD2 plays a key role in normal physiology in the corticosteroid regulation of sodium homeostasis and pathophysiology of hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Heterozygous carriers may have an increased risk of hypertension (598).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [598]
Citations
Cites
Barker, D. J., Osmond, C., Golding, J., Kuh, D., & Wadsworth, M. E. (1989) · BMJ · doi:10.1136/bmj.298.6673.564 · Cited by 2,415 · cited 1×
“Barker’s epidemiological studies indicate a strong correlation between low birth weight at term and cardiovascular disease risk in adulthood, and this has prompted speculation that factors involved in regulating fetal growth might in some way program the subsequent development of hypertension (and other cardiovascular…”
BackgroundArriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946 · cited 1×
“and aldosterone in vitro (4), and the inactivation of cortisol to”
BackgroundMineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationStewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803 · cited 1×
“Licorice administration to normal volunteers results in a mineralocorticoid excess state, an increase in the urinary THF allo-THF/THE ratio, an increase in plasma cortisol half-life, and a decrease in circulating cortisone values, indicative of inhibition of 11 HSD2 in vivo (30, 31).”
BackgroundSelf-citation11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Self-citationCloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
Mune, T., Rogerson, F. M., Nikkilä, H., Agarwal, A. K., & White, P. C. (1995) · Nature Genetics · doi:10.1038/ng0895-394 · Cited by 619
Edwards, C. R. W., Benediktsson, R., Lindsay, R. S., & Seckl, J. R. (1993) · The Lancet · doi:10.1016/0140-6736(93)90148-a · Cited by 548 · cited 1×
“The poor growth rate seen in many children with AME is possibly due to glucocorticoid excess in utero consequent on absent or impaired 11 -HSD2 activity (66, 67).”
Background11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 358
Caprio, M., Newfell, B. G., la Sala, A., Baur, W., Fabbri, A., Rosano, G., Mendelsohn, M. E., & Jaffe, I. Z. (2008) · Circulation Research · doi:10.1161/circresaha.108.174235 · Cited by 285
Nagata, K., Obata, K., Xu, J., Ichihara, S., Noda, A., Kimata, H., Kato, T., Izawa, H., Murohara, T., & Yokota, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000203772.78696.67 · Cited by 223
Salivary cortisone is a potential biomarker for serum free cortisol
Perogamvros, I., Keevil, B. G., Ray, D. W., & Trainer, P. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1215 · Cited by 222
“On the other hand, the combined quantification of these compounds may be used as a tool in the study of 11 -HSD2 activity, in a similar way that the ratio of urinary free cortisol to urinary free cortisone is used for the same purpose (30).”
BackgroundMethodCortisol assays and diagnostic laboratory procedures in human biological fluids
Gatti, R., Antonelli, G., Prearo, M., Spinella, P., Cappellin, E., & De Palo, E. F. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.04.011 · Cited by 214
“inactivation of cortisol to cortisone) to prevent activation of the mineralocorticoid receptor (MR) by cortisol [26,27].”
BackgroundFrom Receptor Balance to Rational Glucocorticoid Therapy
de Kloet, E. R. (2014) · Endocrinology · doi:10.1210/en.2014-1048 · Cited by 208
“The conversion was blocked by glycerrhetinic acid present in licorice enabling the kidney MR to retain tracer (3)H-B, explaining the role of 11 HSD-2 in hypertension (34).”
BackgroundAdrenal Corticosteroid Biosynthesis, Metabolism, and Action
Arlt, W., & Stewart, P. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.002 · Cited by 195
Self-citationCortisol synthesis in epidermis is induced by IL-1 and tissue injury
Vukelic, S., Stojadinovic, O., Pastar, I., Rabach, M., Krzyzanowska, A., Lebrun, E., Davis, S. C., Resnik, S., Brem, H., & Tomic-Canic, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188268 · Cited by 193
Isidori, A. M., Graziadio, C., Paragliola, R. M., Cozzolino, A., Ambrogio, A. G., Colao, A., Corsello, S. M., & Pivonello, R. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000415 · Cited by 185
“It is noteworthy that another isoform of 11beta-HSD, the type-1 (11beta-HSD1), highly expressed in the liver and the adipose tissue, and also in the heart, vascular endothelial and smooth muscle cells, catalyzes the reactivation of cortisone into cortisol, regulating local cortisol bioavailability, and complicating th…”
BackgroundNovel Genomic Effects of Glucocorticoids in Epidermal Keratinocytes
Stojadinovic, O., Lee, B., Vouthounis, C., Vukelic, S., Pastar, I., Blumenberg, M., Brem, H., & Tomic-Canic, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606262200 · Cited by 182
Biomarkers of Psychological Stress in Health Disparities Research
Djuric, Z., Bird, C. E., Furumoto-Dawson, A., Rauscher, G. H., Ruffin IV, M. T., Stowe, R. P., Tucker, K. L., & Masi, C. M. (2008) · The Open Biomarkers Journal · doi:10.2174/1875318300801010007 · Cited by 144
“Glucocorticoid excess adversely affects muscle and skin via atrophy and reduced collagen production, respectively, [54] and also leads to osteoporosis via osteoblast inhibition [55].”
BackgroundPerogamvros, I., Owen, L. J., Newell-Price, J., Ray, D. W., Trainer, P. J., & Keevil, B. G. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.09.014 · Cited by 140
Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension
Frey, F. J., Odermatt, A., & Frey, B. M. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000133976.32559.b0 · Cited by 146
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Licorice and its potential beneficial effects in common oro‐dental diseases
Messier, C., Epifano, F., Genovese, S., & Grenier, D. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01842.x · Cited by 151
“Large amounts of licorice, more particularly glycyrrhizin, may cause severe hypertension, hypokalemia, and hypermineralocorticoid-like effects (Isbrucker and Burdock, 2006) through inhibition of 11b-hydroxysteroid dehydrogenase, which is responsible for the renal conversion of cortisol into cortisone (Quinkler and Ste…”
BackgroundDebono, M., Harrison, R. F., Whitaker, M. J., Eckland, D., Arlt, W., Keevil, B. G., & Ross, R. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3694 · Cited by 128
“This conversion of cortisol to cortisone predominantly reflects the function of 11 -HSD2 in the kidneys as it protects the mineralocorticoid receptor from excess active cortisol by converting it to inactive cortisone (20).”
BackgroundHistopathological Diagnosis of Primary Aldosteronism Using CYP11B2 Immunohistochemistry
Nanba, K., Tsuiki, M., Sawai, K., Mukai, K., Nishimoto, K., Usui, T., Tagami, T., Okuno, H. G., Yamamoto, T., Shimatsu, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3726 · Cited by 129
“It is well known that cortisol has an affinity similar to aldosterone to the mineralocorticoid receptor in the kidney (21).”
BackgroundCortisol metabolism in hypertension
Hammer, F., & Stewart, P. M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.001 · Cited by 143
Self-citationHypertension in Cushing’s Syndrome: From Pathogenesis to Treatment
Cicala, M. V., & Mantero, F. (2010) · Neuroendocrinology · doi:10.1159/000314315 · Cited by 112
“identified a disorder of peripheral cortisol metabolism, characterized by hypertension, hypokalemia, low plasma renin activity and subnormal aldosterone levels, reflecting a deficiency of the 11β-HSD2 enzyme. The disease was called apparent mineralocorticoid excess (AME). Patients with this condition oxidize cortisol…”
BackgroundAntonelli, G., Ceccato, F., Artusi, C., Marinova, M., & Plebani, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.004 · Cited by 111
Epigenetics and arterial hypertension: the challenge of emerging evidence
Friso, S., Carvajal, C. A., Fardella, C., & Olivieri, O. (2014) · Translational research · doi:10.1016/j.trsl.2014.06.007 · Cited by 111
Wudy, S. A., Hartmann, M. F., & Remer, T. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00495.2006 · Cited by 101
Diagnosis and treatment of low‐renin hypertension
Mulatero, P., Verhovez, A., Morello, F., & Veglio, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02898.x · Cited by 111
The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
Barbot, M., Ceccato, F., & Scaroni, C. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00321 · Cited by 104
“In physiological conditions, 11β-HSD2 converts cortisol to cortisone preventing it from binding to MR in target tissues, such as in the renal cortex, the colon, the salivary and sweat glands (16).”
BackgroundLiu, Y., Mladinov, D., Pietrusz, J. L., Usa, K., & Liang, M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvn231 · Cited by 91
Cushing’s Syndrome: All Variants, Detection, and Treatment
Sharma, S. T., & Nieman, L. K. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.006 · Cited by 89
“These findings are similar to those in patients with inactivating mutations of 11bHSD2 who have a syndrome of apparent mineralocorticoid excess (SAME).(25) However, in SAME, the aldosterone and renin levels are suppressed in comparison to those seen in Cushing’s syndrome.”
BackgroundResultInfluentialBeyond Glucocorticoids: Integrating Dehydroepiandrosterone (DHEA) into Animal Welfare Research
Whitham, J. C., Bryant, J. L., & Miller, L. J. (2020) · Animals · doi:10.3390/ani10081381 · Cited by 100
“For instance, in humans, measurement of urinary free cortisol has been the optimal choice for medical diagnoses such as kidney disease [150], hypertension [151] and Cushing’s disease [152].”
BackgroundA Hierarchical Bayesian Model for Next-Generation Population Genomics
Gompert, Z., & Buerkle, C. A. (2011) · Genetics · doi:10.1534/genetics.110.124693 · Cited by 83
“Allelic variants of this gene produce an inherited form of hypertension and an end-stage renal disease (Quinkler and Stewart 2003).”
BackgroundGlucocorticoid excess and hypertension
Baid, S. K., & Nieman, L. K. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0046-0 · Cited by 77
Kumar, A., Aravamudhan, S., Gordic, M., Bhansali, S., & Mohapatra, S. S. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2006.09.035 · Cited by 82
Classic congenital adrenal hyperplasia and puberty
Charmandari, E., Brook, C. G. D., & Hindmarsh, P. C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u077 · Cited by 75
Nuotio-Antar, A. M., Hachey, D. L., & Hasty, A. H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00522.2007 · Cited by 81
“Although use of CBX as a long-term treatment for patients with the metabolic syndrome is limited because of its well-established hypertensive and hypokalemic side effects, resulting from inhibition of renal 11 -HSD2 (45), the results of the present study suggest that specific inhibition of 11 -HSD1 may be particularly…”
BackgroundInherited Tubulopathies of the Kidney: Insights from Genetics.
Downie, M., Garcia, S. C. L., Kleta, R., & Bockenhauer, D. (2020) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.14481119 · Cited by 62
Odermatt, A., & Gumy, C. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.019 · Cited by 81
Structure and Function of the Glucocorticoid Receptor Ligand Binding Domain
Bledsoe, R. K., Stewart, E. L., & Pearce, K. H. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)68002-2 · Cited by 82
Antiinflammatory Steroid Action in Human Ovarian Surface Epithelial Cells
Rae, M. T., Niven, D., Critchley, H., Harlow, C. R., & Hillier, S. G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032225 · Cited by 78
Chen, Z., Li, J., Zhang, J., Xing, X., Gao, W., Lu, Z., & Deng, H. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.04.026 · Cited by 78
Newly discovered endocrine functions of the liver
Rhyu, J., & Yu, R. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i11.1611 · Cited by 76
Cortisol Metabolism in Depressed Patients and Healthy Controls
Römer, B., Lewicka, S., Kopf, D., Lederbogen, F., Hamann, B., Gilles, M., Schilling, C., Onken, V., Frankhauser, P., & Deuschle, M. (2009) · Neuroendocrinology · doi:10.1159/000235904 · Cited by 65
“During stress, 11β-HSD1 activity has been enhanced, which is thought to contribute to the adaptation of the organism to stressors [”
BackgroundGatti, R., Cappellin, E., Zecchin, B., Antonelli, G., Spinella, P., Mantero, F., & Palo, E. F. D. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.06.037 · Cited by 62
Pseudohyperaldosteronism, Liquorice, and Hypertension
Sontia, B., Mooney, J., Gaudet, L., & Touyz, R. M. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07470.x · Cited by 60
Kostadinova, R. M., Nawrocki, A. R., Frey, F. J., & Frey, B. M. (2005) · The FASEB Journal · doi:10.1096/fj.04-2820fje · Cited by 59
Heart Failure With Preserved Ejection Fraction What is Known and Unknown
Yamamoto, K., Sakata, Y., Ohtani, T., Takeda, Y., & Mano, T. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1073 · Cited by 57
Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions
Sugiura, Y., Takeo, E., Shimma, S., Yokota, M., Higashi, T., Seki, T., Mizuno, Y., Oya, M., Kosaka, T., Omura, M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11243 · Cited by 58
Herbs and alternative therapies: Relevance to hypertension and cardiovascular diseases
Vora, C. K., & Mansoor, G. A. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0025-0 · Cited by 55
“It inhibits 11βhydroxysteroid dehydrogenase and, hence, increases levels of cortisol that combine with the mineralocorticoid receptor (an acquired apparent mineralocorticoid excess) [ 46 ].”
BackgroundMini-review: pheochromocytomas causing the ectopic ACTH syndrome
Ballav, C., Naziat, A., Mihai, R., Karavitaki, N., Ansorge, O., & Grossman, A. B. (2012) · Endocrine · doi:10.1007/s12020-012-9646-7 · Cited by 59
“High cortisol levels in CS may act as mineralocorticoids after saturating 11b-hydroxysteroid dehydrogenase type 2, the enzyme responsible for its metabolism, leading to hypokalemia [18].”
BackgroundKhan, N., Sharma, K. K., Andersson, S., & Auchus, R. J. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.05.023 · Cited by 60
Zhang, Q., Chen, Z., Chen, S., Xu, Y., & Deng, H. (2016) · Steroids · doi:10.1016/j.steroids.2016.12.008 · Cited by 57
“The resulting ratio of cortisol to cortisone (Rcc) is the potential biomarker to reliably assess the activity of 11b-hydroxysteriod dehydrogenases (11b-HSD) where 11b-HSD type 1 (11b-HSD1) is responsible for the reversible conversion of cortisone to cortisol and 11b-HSD type 2 (11bHSD2) catalyzes the irreversible conv…”
BackgroundGlucocorticoid-Related Signaling Effects in Vascular Smooth Muscle Cells
Molnár, G. A., Lindschau, C., Dubrovska, G., Mertens, P. R., Kirsch, T., Quinkler, M. O., Gollasch, M., Wresche, S., Luft, F. C., Müller, D. N., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.105718 · Cited by 57
Self-citationQuinkler, M., Zehnder, D., Lepenies, J., Petrelli, M. D., Moore, J. S., Hughes, S. V., Cockwell, P., Hewison, M., & Stewart, P. M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01954 · Cited by 51
“Increased sensitivity to salt is a forerunner to ‘essential’ hypertension and polymorphic variability in the HSD11B2 gene with an impaired 11b-HSD2 activity in part determines salt sensitivity ( 11 , 13, 14).”
BackgroundSelf-citationThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Fallo, F., Di Dalmazi, G., Beuschlein, F., Biermasz, N. R., Castinetti, F., Elenkova, A., Fassnacht, M., Isidori, A. M., Kastelan, D., Korbonits, M., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003252 · Cited by 49
“Copyright © 2022 Wolters Kluwer contributors to the enhanced mineralocorticoid activity in Cushing’s syndrome [105,107].”
BackgroundIncreased glucocorticoid activation during mouse skin wound healing
Tiganescu, A., Hupe, M., Uchida, Y., Mauro, T. M., Elias, P. M., & Holleran, W. M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0420 · Cited by 53
Iob, E., Kirschbaum, C., & Steptoe, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.06.008 · Cited by 55
Tucker–Drob, E. M., Grotzinger, A. D., Briley, D. A., Engelhardt, L. E., Mann, F. D., Patterson, M. W., Kirschbaum, C., Adam, E. K., Church, J. A., Tackett, J. L., et al. (2017) · Psychological Medicine · doi:10.1017/s0033291716003068 · Cited by 52
“In humans, cortisol is metabolized into the inactive cortisone form, which can, in turn, be converted back to active cortisol (Stewart et al. 1999; Quinkler & Stewart, 2013; Rippe et al. 2016).”
BackgroundCheng, H., Dodge, J., Mehl, E., Liu, S., Poulin, N., van de Rijn, M., & Nielsen, T. O. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.01.011 · Cited by 44
“Mean log ratio intensity measurements were retrieved for the clones of interest from the Stanford Microarray Database (http://smd.stanford.edu/).”
MethodUeda, K., Nishimoto, M., Hirohama, D., Ayuzawa, N., Kawarazaki, W., Watanabe, A., Shimosawa, T., Loffing, J., Zhang, M.-Z., Marumo, T., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08966 · Cited by 44
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Self-citationChen, Z., Zhang, Q., Chen, S., Wang, W., Liu, G., & Deng, H. (2019) · Steroids · doi:10.1016/j.steroids.2019.05.010 · Cited by 46
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Cardiovascular risk and mortality in patients with active and treated hypercortisolism
Li, D., El Kawkgi, O. M., Henriquez, A. F., & Bancos, I. (2020) · Gland Surgery · doi:10.21037/gs.2019.11.03 · Cited by 42
Al‐Dujaili, E. A. S., Kenyon, C. J., Nicol, M. R., & Mason, J. I. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.011 · Cited by 41
Al-Dujaili, E. A. S., Munir, N., & Iniesta, R. R. (2016) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018816653357 · Cited by 39
“Cortisone and the cortisol:cortisone ratio have been linked with increased CVD events [Quinkler and Stewart, 2003].”
BackgroundGrapefruit juice and licorice increase cortisol availability in patients with Addison's disease
Methlie, P., Husebye, E. E. S., Hustad, S., Lien, E. A., & Løvås, K. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0518 · Cited by 50
Hunter, R. W., Ivy, J. R., Flatman, P. W., Kenyon, C. J., Craigie, E., Mullins, L. J., Bailey, M. A., & Mullins, J. J. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060634 · Cited by 38
Steroids - From Physiology to Clinical Medicine
Ostojić, S. M. (2012) · InTech eBooks · doi:10.5772/46119 · Cited by 41
“[87] Takase K, Funabashi T, Mogi K, Mitsushima D, Kimura F (2005a) Feeding with pow‐ dered diet after weaning increases visuospatial ability in association with increases in the expression of N-methyl-D-aspartate receptors in the hippocampus of female rats.”
BackgroundBeck, B. R., Park, G.-S., Jeong, D. Y., Lee, Y. H., Im, S., Song, W. H., & Kang, J. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00269 · Cited by 42
Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children
Remer, T., Maser‐Gluth, C., Boye, K. R., Hartmann, M. F., Heinze, E., & Wudy, S. A. (2006) · Steroids · doi:10.1016/j.steroids.2006.02.005 · Cited by 45
Deluca, D., Krazeisen, A., Breitling, R., Prehn, C. P., Möller, G., & Adamski, J. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.035 · Cited by 37
Thyrotoxic Periodic Paralysis Induced by Pulse Methylprednisolone
Wongraoprasert, S., Buranasupkajorn, P., Sridama, V., & Snabboon, T. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0044 · Cited by 37
“Steroids can also cause muscle weakness from renal potassium loss (8) and myopathy (9).”
BackgroundWang, Y., Liu, Z., Liu, C., Liu, R., Yang, C., Wang, L., & Song, L. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.05.010 · Cited by 42
Glucocorticoid-induced fetal origins of adult hypertension: Association with epigenetic events
Anwar, M. A., Saleh, A. I., Olabi, R. A., Shehabi, T. S. A., & Eid, A. H. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.02.002 · Cited by 41
Water Metabolism and Diabetes Insipidus
Nelson, R. W. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4456-5.00001-8 · Cited by 37
Molecular basis for the Apparent Mineralocorticoid Excess Syndrome in the Oman population
Quinkler, M. O., Bappal, B., Draper, N. R., Atterbury, A., Lavery, G. G., Walker, E. A., Desilva, V. R., Taylor, N., Hala, S., Rajendra, N., et al. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.019 · Cited by 41
Self-citationInherited forms of mineralocorticoid hypertension
Hassan-Smith, Z., & Stewart, P. M. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283469444 · Cited by 36
Self-citationRenin and Aldosterone Measurements in the Management of Arterial Hypertension
Viola, A., Monticone, S., Burrello, J., Buffolo, F., Lucchiari, M., Rabbia, F., Williams, T. A., Veglio, F., Mengozzi, G., & Mulatero, P. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1548868 · Cited by 39
Craigie, E., Evans, L. C., Mullins, J. J., & Bailey, M. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196410 · Cited by 40
“Nevertheless, the current dose was found previously to be effective against similar concentrations of glucocorticoid,(8) and although spironolactone treatment can improve both the hypertension and hypokalemia observed in AME,(27) it is of variable benefit in long-term treatment.(28) We found that chronic GR blockade n…”
Moler, E. R. V., Abakir, A., Eleftheriou, M., Johnson, J. S., Krutovsky, K. V., Lewis, L. C., Ruzov, A. S., Whipple, A. V., & Rajora, O. P. (2018) · Population genomics · doi:10.1007/13836_2018_59 · Cited by 40
Gunaratne, M. D. S. K., Thorsteinsdottir, B., & Garovic, V. D. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01147-4 · Cited by 39
At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension
Grinsell, M. M., & Norwood, V. F. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0744-y · Cited by 36
“Hypertension from licorice responds to pharmacologic therapy with spironolactone and eplerenone in animal models [ 67 , 70].”
BackgroundInfluentialAn HPLC method for the determination of the free cortisol/cortisone ratio in human urine
Al Sharef, O., Feely, J., Kavanagh, P. V., Scott, K. R., & Sharma, S. C. (2007) · Biomedical Chromatography · doi:10.1002/bmc.877 · Cited by 35
Grau, J., Benedé, J. L., Chisvert, A., & Salvador, A. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2021.462361 · Cited by 35
Müssig, K., Remer, T., Haupt, A., Gallwitz, B., Fritsche, A., Häring, H., & Maser‐Gluth, C. (2008) · Obesity · doi:10.1038/oby.2008.218 · Cited by 38
“Global activity of 11β-HSD1 was conventionally assessed by the ratio (5α-THF + THF)/ THE (22) and the net balance between 5α- and 5β-reductase by the ratio 5α-THF/THF (23,24).”
MethodInfluentialEvaluation and Treatment of Patients With Hypercortisolism: A Review
Miller, B. S., & Auchus, R. J. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.3280 · Cited by 37
Adaptation of the hypothalamic‐pituitary hormones during intensive endurance training
Bobbert, T., Brechtel, L. M., Mai, K., Otto, B., Maser‐Gluth, C., Pfeiffer, A. F. H., Spranger, J., & Diederich, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02377.x · Cited by 34
Antonelli, G., Artusi, C., Marinova, M., Brugnolo, L., Zaninotto, M., Scaroni, C. M., Gatti, R. D., Mantero, F., & Plebani, M. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0471 · Cited by 32
Goldstein, J., Cherkerzian, S., Buka, S., Fitzmaurice, G., Hornig, M., Gillman, M., O'Toole, S., & Sloan, R. (2011) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174411000651 · Cited by 32
Two types of ectopic Cushing syndrome or a continuum? Review
Castro, M. A., & Marazuela, M. (2018) · Pituitary · doi:10.1007/s11102-018-0894-2 · Cited by 32
Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney
Dunbar, D. R., Khaled, H., Evans, L. C., Al‐Dujaili, E. A. S., Mullins, L. J., Mullins, J. J., Kenyon, C. J., & Bailey, M. A. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.00088.2009 · Cited by 29
Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism
Schilbach, K., Junnila, R. K., & Bidlingmaier, M. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0672-0836 · Cited by 38
“Furthermore, a decrease in PRA and in aldosterone concentrations occurs [61].”
BackgroundPlenis, A., Konieczna, L., Olędzka, I., Kowalski, P., & Bączek, T. (2011) · Molecular BioSystems · doi:10.1039/c0mb00313a · Cited by 31
Youssef, L., Crovetto, F., Simoes, R. V., Miranda, J., Paulés, C., Blasco, M., Palomo, M., García‐Calderó, H., Tura-Ceide, O., Dantas, A. P., et al. (2022) · Life · doi:10.3390/life12010086 · Cited by 28
“This imbalance might contribute to high blood pressure in preeclampsia, obesity, renal disease and other hypertensive disorders [37].”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Nutritional recommendations for patients undergoing prolonged glucocorticoid therapy
Esteves, G. P., Mazzolani, B. C., Smaira, F. I., Mendes, E. S., Oliveira, G. G., Roschel, H., Gualano, B., Pereira, R. M. R., & Dolan, E. (2022) · Rheumatology Advances in Practice · doi:10.1093/rap/rkac029 · Cited by 32
“GCs are also known to interact with the mineralo-corticoid receptor, therefore mimicking the role of aldosterone [120] and increasing renal sodium and water retention (Fig.”
Zhang, J., Li, J., Xu, Y., Yang, J., Chen, Z., & Deng, H. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.08.022 · Cited by 29
Lee, S.-H., Kwon, S.-H., Shin, H.-J., Lim, H.-S., Singh, R. J., Lee, K.-R., & Kim, Y.-J. (2010) · BMB Reports · doi:10.3858/bmbrep.2010.43.7.506 · Cited by 26
“importance for the corticosteroid regulation of sodium homeostasis, the pathophysiology of hypertension and an inherited genetic disease caused by an enzyme defect (8).”
BackgroundPeti, A. P. F., Locachevic, G. A., Prado, M. K. B., de Moraes, L. A. B., & Faccioli, L. H. (2018) · Journal of Mass Spectrometry · doi:10.1002/jms.4075 · Cited by 28
Advances in the assessment of cortisol exposure and sensitivity
Wester, V. L., Lamberts, S. W. J., & van Rossum, E. F. C. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000077 · Cited by 24
Hough, D., Swart, P., & Cloete, S. W. P. (2013) · Animals · doi:10.3390/ani3020442 · Cited by 26
“In these tissues 11 HSD2 “defends” the mineralocorticoid receptor from excess glucocorticoids (able to bind to this receptor) [108,150].”
Background
Metadata
- Authors
- Quinkler, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2384-2392
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2087582614
- Semantic Scholar
- 776fe230acf2defba35d92035bb5d6c7ce782d64
- Cited by
- 286
- References
- 70
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 14 · 2023: 13 · 2022: 8 · 2021: 10 · 2020: 15 · 2019: 6 · 2018: 11 · 2017: 11 · 2016: 10 · 2015: 13 · 2014: 12 · 2013: 13 · 2012: 14
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hypertension, 11β-hydroxysteroid dehydrogenase type 2, mineralocorticoid receptor, apparent mineralocorticoid excess, licorice, carbenoxolone, preeclampsia, sodium retention, Cushing's syndrome, ectopic ACTH syndrome, salt sensitivity, Barker hypothesis, fetal growth restriction, sodium homeostasis, substrate saturation
- MeSH terms
- Cortisone, Humans, Hydrocortisone, Hydroxysteroid Dehydrogenases, Hypertension, Mineralocorticoids, 11-beta-Hydroxysteroid Dehydrogenase Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.